MPZL3 and ovarian carcinoma: To determine whether MPZL3 has CAM properties in ovarian cancer cells, we tested the effects of MPZL3 knockdown in OVCAR4 cells on homotypic cell adhesion by quantifying their attachment to a monolayer of parental OVCAR4 cells, and assessing their heterotypic adhesion to mesothelial cells.